Medtronic (MDT)
92.44
+0.47 (0.51%)
NYSE · Last Trade: Jul 29th, 6:34 PM EDT
Detailed Quote
Previous Close | 91.97 |
---|---|
Open | 91.82 |
Bid | 91.75 |
Ask | 92.75 |
Day's Range | 91.75 - 92.71 |
52 Week Range | 78.60 - 96.25 |
Volume | 4,676,801 |
Market Cap | 124.23B |
PE Ratio (TTM) | 25.54 |
EPS (TTM) | 3.6 |
Dividend & Yield | 2.800 (3.03%) |
1 Month Average Volume | 7,059,793 |
Chart
About Medtronic (MDT)
Medtronic is a global leader in medical technology, focused on developing and providing innovative therapeutic solutions to improve the lives of patients. The company specializes in a wide range of medical devices and therapies, addressing conditions in areas such as diabetes care, cardiovascular health, surgical innovations, and neurological disorders. Medtronic is committed to advancing healthcare through cutting-edge research, collaboration with healthcare providers, and a strong emphasis on patient-centered care, aiming to enhance the quality of life for millions around the world. Read More
News & Press Releases
Koninklijke Philips N.V. (AMS:PHIA), commonly known as Philips, is one of the most storied companies in the history of European industry. Founded in 1891 in Eindhoven, Netherlands, Philips has evolved from a modest light bulb manufacturer into a global leader in health technology and medical innovation. Its transformation
Via MarketMinute · July 29, 2025
July 29, 2025 -- Longtime Member and FOMAT CEO Nicholas Focil Appointed to Lead Global Research Site Network
Via 24-7 Press Release · July 29, 2025
If you're looking for high-yield stocks in the healthcare sector, it's hard to beat this trio of industry giants offering yields of up to 3.9%.
Via The Motley Fool · July 28, 2025
Via Benzinga · July 28, 2025
CMS’s Initial Proposal To Cover Renal Denervation A Win For Medtronic, Says Analystsstocktwits.com
Via Stocktwits · July 11, 2025
Via The Motley Fool · July 23, 2025
Via The Motley Fool · July 23, 2025
The Federal Circuit overturned a $106 Million verdict against Medtronic, ruling that Colibri was barred from claiming patent infringement.
Via Benzinga · July 21, 2025
These S&P 500 dividend stocks have fallen by up to 33% and are best buys now.
Via The Motley Fool · July 20, 2025
The move wiped out all of the gains Sarepta lodged Thursday after announcing its restructuring plans.
Via Investor's Business Daily · July 18, 2025
The company's second biggest product missed sales expectations. Shares look likely to undercut a buy zone.
Via Investor's Business Daily · July 17, 2025
The company issued a light outlook for 2025 organic sales growth despite beating second-quarter forecasts.
Via Investor's Business Daily · July 17, 2025
MEDTRONIC PLC (NYSE:MDT) appears undervalued with strong profitability, a solid dividend, and stable financials, making it a candidate for value investors.
Via Chartmill · July 17, 2025
The company is also restructuring with the hopes of saving $400 million in expenses.
Via Investor's Business Daily · July 16, 2025
Australia, July 16, 2025 -- Not Just a Patch, a developer of medical CGM covers and patches solutions, has received U.S. Food and Drug Administration (FDA) clearance and European Class 1 medical device certification for its line of waterproof adhesive patches designed for continuous glucose monitoring (CGM) devices. These regulatory milestones will allow the company to expand its distribution footprint across North America and Europe, reinforcing market confidence in its CGM support products.
Via Press Release Distribution Service · July 16, 2025
Via Benzinga · July 16, 2025
MEDTRONIC PLC (NYSE:MDT) offers a solid 3.18% dividend yield, strong profitability, and reasonable valuation, making it a candidate for dividend investors. The company has a reliable payout history and decent financial health.
Via Chartmill · July 15, 2025
Robotics adoption is accelerating globally, with AI, automation, and real-time data processing reshaping industries from healthcare to manufacturing.
Via MarketBeat · July 14, 2025
Bank of America names its highest-conviction stock ideas for Q3 2025—8 Buys and 2 Underperforms. Boeing, Cisco, and Datadog top the list.
Via Benzinga · July 12, 2025
CMS proposed Medicare coverage for Medtronic's renal denervation therapy for high blood pressure, signaling a key step toward broader adoption.
Via Benzinga · July 11, 2025
Via The Motley Fool · July 11, 2025
A steady dose of quality companies will keep your portfolio growing big and strong.
Via The Motley Fool · July 11, 2025